Quantcast

Latest Pancreatic duct Stories

2014-08-06 23:11:27

CDI, The Miami Center for Diagnostic Imaging, announces upgraded MRCP scans for better prevention and diagnosis of biliary and pancreatic duct systems. Miami, FL (PRWEB) August 06, 2014 CDI, the Miami Center for Diagnostic Imaging, announces upgraded MRCP scans for better prevention and diagnosis of biliary and pancreatic duct systems. MRCP, magnetic resonance cholangiopancreatoography, is a less costly, non-invasive, and sensitive technique for evaluating the biliary and pancreatic...

2014-05-28 14:29:39

The JAMA Network Journals In certain patients with abdominal pain after gallbladder removal (cholecystectomy), undergoing an endoscopic procedure involving the bile and pancreatic ducts did not result in fewer days with disability due to pain, compared to a placebo treatment, according to a study in the May 28 issue of JAMA. Post-cholecystectomy pain is a common clinical problem. More than 700,000 patients undergo cholecystectomy each year in the United States, and at least 10 percent...

2014-05-17 23:01:16

The Firm is investigating Byetta lawsuits on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis and thyroid cancer due to their use of the Type 2 diabetes medication. New York, New York (PRWEB) May 17, 2014 Byetta lawsuits (http://www.byettalawsuit.com) and other product liability claims involving a class of diabetes drugs called incretin mimetics continue to mount in a federal multidistrict litigation now underway in U.S. District Court, Southern District of...

2013-09-30 23:22:37

The Firm is currently investigating Byetta lawsuits on behalf of patients who may have developed pancreatic cancer due to the use of the Type 2 diabetes drug. New York, NY (PRWEB) September 30, 2013 Dozens of Byetta lawsuit (http://www.byettalawsuit2013.com/) claims filed on behalf of plaintiffs who allegedly developed pancreatic cancer due to their use of the Type 2 diabetes drug have begun to move forward in a multidistrict litigation recently established in U.S. District Court,...

2013-07-13 23:03:36

The Firm is investigating Byetta lawsuits on behalf of individuals treated with the type 2 diabetes drug who went on to develop pancreatic cancer, pancreatitis and thyroid cancer. New York, New York (PRWEB) July 13, 2013 As Bernstein Liebhard LLP continues to investigate Byetta pancreatic cancer lawsuits, the firm notes that the drug has been the subject of a growing number of reports to the U.S. Food & Drug Administration (FDA) that involve pancreatic cancer, pancreatitis and...

2012-04-12 09:52:52

Dozens of therapies have been tried, but study led by University of Michigan physicians is first to show effective prevention of post-ERCP pancreatitis A study in the current issue of the New England Journal of Medicine shows a serious complication of ERCP, a procedure commonly used to diagnose and treat problems of the bile and pancreatic ducts, may be eliminated with a single dose medication. The finding is significant in helping patients avoid a condition known as post-ERCP...

2010-05-27 05:00:00

WALTHAM, Mass., May 27 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read). The FDA and EMA have agreed to the Phase 3 re-read based on the numerous...

2010-05-12 11:52:23

A recent case report published on May 14, 2010 in World Journal of Gastroenterology describes the imaging features of a ruptured superior mesenteric artery aneurysm, which created a giant hematoma and mimicked a pancreatic mass, with mild dilatation of main pancreatic duct. Previous studies have shown how pancreatic disease can be simulated by various anatomical structures in the retroperitoneal region at the pancreatic level. Aneurysm of the hepatic artery, for example, simulates pancreatic...

2009-12-09 05:00:00

WALTHAM, Mass., Dec. 9 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) reported today top-line results from a Phase 3 clinical trial to evaluate the safety and efficacy of RG1068, synthetic human secretin, to improve magnetic resonance imaging (MRI) of the pancreas in patients with a history of pancreatitis. The study's co-primary endpoints were improvements in sensitivity of detection of structural abnormalities of the pancreatic ducts using RG1068 in combination with MRI...

2008-08-29 03:00:19

By Kim, Tad Grobmyer, Stephen R; Dixon, Lisa R; Hochwald, Steven N We present an interesting case of a 62-year-old woman with a 3- month history of vague, left-sided abdominal pain. CT imaging revealed a hypodense lesion in the tail of the pancreas. The patient had no history of pancreatitis or autoimmune diseases. Laboratory testing revealed a normal CA19-9 (33 U/mL) and an elevated IgG4 (133 mg/dL). Due to concerns of pancreatic malignancy, she underwent operation. We found a dense,...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related